Cafepharma Today

June 10 2025 - Novo Nordisk starts new CagriSema weightloss drug trial
Novo Nordisk starts new CagriSema weightloss drug trial
Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up
A medical device trade war is brewing between the EU and China
Merck antibody drug for RSV approved by FDA
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Scrappy Upstarts Aiming For Pfizer's Xalkori Market
Seeking Alpha
Monday, June 3, 2013 - 11:29am
tags:
Pfizer, Xalkori, Tesaro, Ariad Pharmaceuticals, AP26113, lung cancer, TSR-011
Merck jumps on melanoma treatment results
Marketwatch
Monday, June 3, 2013 - 11:26am
tags:
Merck, melanoma, lambrolizumab, ASCO
The Fast Paced World Of Advanced Cell Technology: An Interview With Chairman And CEO Gary Rabin
Seeking Alpha
Monday, June 3, 2013 - 11:17am
tags:
Advanced Cell Technology, Gary Rabin, Merck, Novartis, Pfizer, stem cells, adult stem cells
Cancer Drug Shortages Force Doctors to Ration, Delay Treatment
Bloomberg
Monday, June 3, 2013 - 10:59am
tags:
drug shortages, ASCO, physicians
Sanofi Ends Iniparib Research, Plans $285 Million Charge
Bloomberg
Monday, June 3, 2013 - 10:37am
tags:
iniparib, Sanofi, lung cancer
A Premature Death? KV Pharma And Makena Make An Unexpected Comeback
Pharmalot
Monday, June 3, 2013 - 10:35am
tags:
KV Pharmaceutical, Makena
Synta's Lung Cancer Drug Struggles to Remain Relevant
TheStreet.com
Monday, June 3, 2013 - 10:31am
tags:
Synta Pharmaceuticals, lung cancer, ganetespib
Drugs Go From Hit to Dud in Two Years in Hepatitis Race
Bloomberg
Monday, June 3, 2013 - 10:27am
tags:
hepatitis C, Merck, Gilead, Vertex Pharmaceuticals, JNJ, Medivir, Bristol-Myers Squibb
Bristol And Merck's Cancer Drugs Won ASCO. Five Slides Explain Why.
TheStreet.com
Monday, June 3, 2013 - 10:20am
tags:
nivolumab, Merck, melanoma, lambrolizumab, Bristol-Myers Squibb, ASCO
Keryx announces positive Zerenex Phase 3 data
Yahoo/Fly on the Wall
Monday, June 3, 2013 - 10:12am
tags:
Zerenex, Keryx, hyperphosphatemia
FDA panel to consider lifting restrictions on Avandia based on new heart risk analysis
Yahoo/AP
Monday, June 3, 2013 - 10:11am
tags:
FDA, Avandia, GSK, diabetes
Teva on both sides in patent lawsuits
phily.com, PA
Sunday, June 2, 2013 - 12:09pm
tags:
Teva Pharmaceuticals, lawsuits, generics
Merck Rushes Forward In Race To Market Cell Death Cancer Drugs
Forbes
Sunday, June 2, 2013 - 11:56am
tags:
Merck, lambrolizumab, melanoma
Merck's Anti-PD1 Melanoma Drugs Shrinks Tumors In Half of Patients
The Street
Sunday, June 2, 2013 - 11:54am
tags:
Merck, labrolizumab, melanoma
Roche's Avastin fails to prolong survival in brain cancer study
Reuters
Sunday, June 2, 2013 - 11:52am
tags:
Roche, Avastin, glioblastoma, brain cancer
Longer use of tamoxifen shown to cut risk of breast cancer recurrence
Reuters
Sunday, June 2, 2013 - 11:50am
tags:
tamoxifen, breast cancer
China Biotech In Review: Valeant Pharma Gains Sales Foothold In China With Bausch & Lomb Buy
Seeking Alpha
Sunday, June 2, 2013 - 11:49am
tags:
Valeant Pharmaceuticals, Bausch & Lomb, BeiGene, Merck Serono, Winteam Pharma, Tongjitang Chinese Medicines, Qiagen, Aslan Pharma, Sinovac Biotech, Vigoo Biological
Which of These Billion-Dollar Biotechs Is a Buy?
Motley Fool
Sunday, June 2, 2013 - 11:45am
tags:
Amarin, Lexicon Pharmaceuticals
Infinity Reports Updated Phase 1 Data Showing Encouraging Clinical Activity of IPI-145 in Chronic Lymphocytic Leukemia at ASCO Annual Meeting
Yahoo/BusinessWire
Sunday, June 2, 2013 - 11:44am
tags:
IPI-145, Infinity Pharmaceuticals, leukemia, chronic lymphocytic leukemia
Seattle Genetics Highlights Adcetris (Brentuximab Vedotin) Frontline HL and MTCL Clinical Development Programs and Antibody-Drug Conjugate (ADC) Collaborator Data at ASCO Annual Meeting
Yahoo/BusinessWire
Sunday, June 2, 2013 - 11:43am
tags:
Seattle Genetics, Adcetris, T-cell lymphoma, systemic anaplastic large cell lymphoma, Hodgkin's lymphoma

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.